管理I期临床试验风险的要求:英国和意大利的案例研究
Davide Di Tonno1,2, Laura Martena1, Manuela Taurisano1,2
1ClinOpsHub srl., 72023 Mesagne, Italy.
Epidemiologia (Basel, Switzerland)
|March 27, 2024
概括
一期临床试验对于药物安全性和确定最大耐受剂量 (MTD) 至关重要. 欧洲指导方针,包括MHRA和AIFA法规,协调这些早期人类研究的风险管理.
科学领域:
- 临床药理学和药物开发
- 医药领域的监管事务
- 临床研究中的患者安全.
背景情况:
- 第一阶段临床试验是研究中药物的首次人体试验.
- 确定最大耐受剂量 (MTD) 和安全性在早期药物开发中至关重要.
- 欧洲监管机构提供了在第一阶段试验中协调风险管理的指导方针.
研究的目的:
- 提供欧洲临床试验第一阶段风险管理指南的概述.
- 要突出英国的MHRA和意大利的AIFA (决定号) 的具体规定. 809/2015年) 的建议.
- 讨论在第一阶段研究中应用的质量风险管理原则.
主要方法:
- 审查欧洲指南和监管文件 (MHRA,AIFA).
- 在I期临床试验中的风险管理策略的分析.
- 专注于非营利性第一阶段试验的具体要求.
主要成果:
- 无论是MHRA还是AIFA,都强调I期试验的质量风险管理.
- 国际足联的决定号. 809/2015详细说明了非营利性第一阶段试验和"临床试验质量团队"的要求.
- 这些指导方针旨在协调并提供有关在药物开发早期阶段管理风险的规定.
结论:
- 遵守MHRA和AIFA指南对于安全有效的I期临床试验至关重要.
- 质量风险管理是早期药物开发监管期望的基石.
- 具体的意大利法规通过专门的质量团队支持非营利性第一阶段试验.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.2K
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Hazard Ratio
118
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
118
Methods of Documentation VI: Case Management Model
571
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
571
Nursing Ethical Principles II
958
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
958
Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
